The 43% Acceptance Problem: Why Your Patient Financing Strategy Is Hemorrhaging Revenue

Here's a number that should make every practice owner uncomfortable: According to recent data from the American Dental Association's Practice Management Institute, 43% of treatment plans valued over $1,000 are declined or deferred due to financial constraints. That's nearly half of your potential revenue walking out the door.

But here's what's really maddening—most practices are throwing money at the wrong solution. They're signing up with every financing company that knocks on their door, thinking more options equal better acceptance rates. The reality? Practices offering four or more financing options actually see lower conversion rates than those offering two well-chosen alternatives.

"I used to think I was being helpful by giving patients every possible financing option," admits Dr. Jennifer Walsh, DDS, who runs a general practice in Omaha. "CareCredit, Sunbit, LendingClub, plus our in-house plans. Patients would get overwhelmed and choose nothing."

The financing landscape has exploded in the past five years. Where CareCredit once dominated with minimal competition, practices now field calls from dozens of companies promising better approval rates, lower fees, or faster processing. But the paradox of choice is real, and it's costing practices serious money.

The CareCredit Reality Check

Let's address the elephant in the room first. CareCredit still commands roughly 60% of the dental financing market, and for good reason—brand recognition. Patients know the name, which eliminates the trust barrier that kills so many financing applications before they start.

But CareCredit's fee structure tells a different story. The standard rate hovers around 3.2% for promotional financing plans, with a hefty $39 application fee that practices often absorb. For non-promotional plans, you're looking at fees ranging from 10.9% to 17.9%—rates that can make a $3,000 crown feel like a $3,500 investment for the patient.

The bigger issue? CareCredit's approval rates have been declining. Internal data from a network of 180 practices shows approval rates dropped from 71% in 2019 to 63% in 2023. The company tightened credit requirements during the pandemic and hasn't loosened them back to pre-2020 levels.

"We were seeing patients with 720 credit scores getting denied," says Dr. Marcus Martinez70, DMD, who operates two locations in suburban Phoenix. "That's when I knew we needed alternatives."

The Sunbit Surge

Enter Sunbit, the Israeli fintech company that's been aggressively courting dental practices since 2020. Their pitch is compelling: approval rates consistently above 80%, no application fees for practices, and a payment processing system that works through patients' smartphones.

Sunbit's secret sauce lies in their underwriting algorithm, which considers over 1,000 data points beyond traditional credit scores. They're approving patients that CareCredit routinely rejects—but at what cost?

The fee structure is where things get interesting. Sunbit charges practices between 3.5% and 6.8%, depending on the payment plan length and patient credit profile. Higher than CareCredit's promotional rates, but lower than their non-promotional options. The real kicker? Sunbit pays practices within 24 hours, compared to CareCredit's 2-3 business day standard.

"The speed of payment alone changed our cash flow dynamics. We went from floating $15,000-20,000 in pending financing to having same-day access to treatment revenue." —Dr. Marcus Martinez168, DMD

But Sunbit isn't without drawbacks. Brand recognition remains low—only 23% of dental patients recognize the Sunbit name, according to a 2023 survey by Dental Economics. This creates friction during the financing conversation that practices must navigate carefully.

The Alternative Landscape

Beyond the big two, a constellation of newer players is reshaping patient financing. LendingClub Health emerged from the peer-to-peer lending space with competitive rates but inconsistent approval criteria. Proceed Finance targets higher-credit patients with premium service but limited payment flexibility.

Then there's the in-house financing renaissance. Practices are rediscovering the power of practice-managed payment plans, often with surprising results. A study by Practice Management Solutions found that practices offering robust in-house financing options saw 23% higher treatment acceptance rates compared to those relying solely on third-party financing.

"We started offering 12-month, zero-interest in-house plans for treatments under $2,500," explains Dr. Sarah Mitchell, DMD, a periodontist in Austin. "Our acceptance rate for periodontal therapy jumped from 54% to 78%. Patients trust us more than they trust a credit card company."

The numbers support this approach. In-house financing typically costs practices 2-4% in administrative overhead and bad debt, compared to 3-7% in fees for third-party options. But the real advantage is control—practices can modify terms, work with struggling patients, and build stronger relationships.

The Fee Structure Deep Dive

Here's where most practices get burned: they don't understand the true cost of financing options. It's not just the obvious transaction fees.

CareCredit's promotional financing looks attractive at 3.2%, but factor in the deferred interest trap. If a patient misses the promotional period by even one day, they're hit with retroactive interest at rates often exceeding 26%. This creates patient relations nightmares that practices end up managing.

Sunbit's higher upfront fees come with a trade-off: no deferred interest gotchas. Patients know exactly what they're paying from day one. This transparency reduces angry phone calls to your office, but it also means some patients will choose to delay treatment rather than accept the higher effective cost.

The hidden cost that kills many practices? Processing time for declined applications. The average financing application takes 8-12 minutes of staff time. When approval rates drop below 60%, you're burning significant labor costs on applications that generate zero revenue.

"We tracked our financing overhead for six months and discovered we were spending 14 hours per week on declined applications," notes Dr. Walsh. "At $25 per hour for front desk staff, that's $18,200 annually in wasted labor."

The Acceptance Rate Reality

The dirty secret of patient financing is that acceptance rates vary wildly based on presentation, not just approval. Practices that position financing as a standard part of treatment planning see acceptance rates 40-60% higher than those that treat it as a last resort.

Training matters enormously. Practices where treatment coordinators receive quarterly financing education report average acceptance rates of 67%, compared to 41% for practices with minimal training protocols.

Timing matters too. Applications submitted before noon on Tuesday through Thursday show 15% higher approval rates across all financing platforms—a pattern that likely reflects both patient attention levels and lender processing schedules.

Building the Optimal Mix

So what's the winning formula? Data from high-performing practices suggests a three-tier approach works best:

**Tier 1:** In-house financing for treatments under $2,000. This captures quick-decision patients and keeps more revenue in-house.

**Tier 2:** One established player (usually CareCredit) for brand recognition and promotional financing options.

**Tier 3:** One alternative provider (Sunbit, LendingClub, or regional options) for patients who don't qualify elsewhere.

Practices using this model report average acceptance rates of 72% for financed treatments, compared to 58% for practices offering either too few or too many options.

The Technology Factor

The financing game is increasingly becoming a technology play. Sunbit's smartphone-based applications process in under three minutes. CareCredit's updated mobile app reduces application abandonment by 31%. Even in-house financing benefits from modern payment processing and automated billing systems.

But technology cuts both ways. The same algorithms that approve more patients also collect data that influences future credit decisions. Practices need to understand how their patient demographics affect approval rates and adjust their financing mix accordingly.

"We noticed our approval rates dropping in late 2022 and couldn't figure out why," recalls Dr. Martinez91. "Turns out, our patient base was getting younger and had less established credit. We had to pivot our financing strategy to match our demographic reality."

Looking Forward: The Evolution Continues

The patient financing landscape will continue fragmenting as fintech companies target healthcare. Apple Pay Later and similar buy-now-pay-later services are already appearing in dental offices, though their impact remains minimal.

More significantly, insurance companies are experimenting with financing products that bridge the gap between covered and elective procedures. These hybrid products could reshape how practices approach treatment planning for borderline-necessary procedures.

The practices that will thrive are those that view financing not as a necessary evil, but as a strategic tool for patient care and revenue optimization. That means regular analysis of approval rates, fee structures, and patient satisfaction metrics.

Because at the end of the day, the best financing option is the one that gets patients to say yes to optimal treatment. And right now, too many practices are leaving that revenue on the table.